Impax Asset Management Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,845
| Closed | -$661K | – | 373 |
|
|
2023
Q3 | $661K | Sell |
1,845
-34
| -2% | -$12.2K | ﹤0.01% | 305 |
|
|
2023
Q2 | $712K | Buy |
1,879
+800
| +74% | +$303K | ﹤0.01% | 304 |
|
|
2023
Q1 | $517K | Hold |
1,079
| – | – | ﹤0.01% | 329 |
|
|
2022
Q4 | $454K | Sell |
1,079
-43
| -4% | -$18.1K | ﹤0.01% | 327 |
|
|
2022
Q3 | $468K | Sell |
1,122
-46
| -4% | -$19.2K | ﹤0.01% | 327 |
|
|
2022
Q2 | $578K | Hold |
1,168
| – | – | ﹤0.01% | 313 |
|
|
2022
Q1 | $658K | Sell |
1,168
-6
| -0.5% | -$3.38K | ﹤0.01% | 323 |
|
|
2021
Q4 | $887K | Sell |
1,174
-32
| -3% | -$24.2K | ﹤0.01% | 299 |
|
|
2021
Q3 | $900K | Hold |
1,206
| – | – | ﹤0.01% | 293 |
|
|
2021
Q2 | $777K | Hold |
1,206
| – | – | ﹤0.01% | 308 |
|
|
2021
Q1 | $689K | Buy |
+1,206
| New | +$689K | ﹤0.01% | 317 |
|